Bovie Medical Corporation to Participate in the 9th Annual Craig-Hallum Alpha Select Conference

Bovie Medical Corporation BVX (the "Company"), a medical technology company and the developer of J-Plasma®, a patented surgical product marketed and sold under the Renuvion™ Cosmetic Technology brand in the cosmetic surgery market, today announced that management will participate in the 9th Annual Craig-Hallum Alpha Select Conference at the Sheraton New York Times Square Hotel in New York, New York. Management will host one-on-one meetings with investors at the conference on Thursday, November 15.

About Bovie Medical Corporation:

Bovie Medical Corporation is a medical technology company and the developer of J-Plasma® (marketed and sold under the Renuvion™ Cosmetic Technology brand in the cosmetic surgery market), a patented plasma-based surgical product for cutting, coagulation and ablation of soft tissue. J-Plasma technology utilizes a helium ionization process to produce a stable, focused beam of plasma that provides surgeons with greater precision, and minimal invasiveness. The Company also leverages its expertise through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Bovie Medical Corporation website at www.boviemedical.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181031005179/en/